The most commonly reported side effects of bethanidine include tubulointerstitial nephritis, chronic kidney disease, and tubulointerstitial nephritis, based on 2 FDA adverse event reports from 2012 to 2014.
Percentages show how often each reaction appears relative to total reports for bethanidine.
These are voluntary reports and do not establish that bethanidine caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside bethanidine. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
100.0% of bethanidine adverse event reports involve female patients and 0.0% involve male patients. The largest age group is elderly at 100%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking bethanidine when the adverse event was reported.
Bethanidine is sold under the brand name Tenathan.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.